Patch testing with a textile dye mix with and without Disperse Orange 3.


Journal

Contact dermatitis
ISSN: 1600-0536
Titre abrégé: Contact Dermatitis
Pays: England
ID NLM: 7604950

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 17 04 2020
revised: 04 07 2020
accepted: 13 07 2020
pubmed: 16 7 2020
medline: 6 7 2021
entrez: 16 7 2020
Statut: ppublish

Résumé

The textile dye mix (TDM) 6.6% pet. contains Disperse Blue (DB) 35, Disperse Yellow 3, Disperse Orange (DO) 1 and 3, Disperse Red 1 and 17, and DB 106 and 124. The most frequent allergen in TDM-positive patients is DO 3. Around 85% of p-phenylenediamine (PPD)-allergic dermatitis patients have shown positive patch test reactions to DO 3. There has been a discussion to exclude DO 3 from TDM 6.6% because of frequent, strong reactions to TDM 6.6% and PPD. To study if DO 3 can be omitted from a TDM. Patch tests were performed on 2250 dermatitis patients with TDM 6.6%, TDM 5.6% pet., TDM 7.0% pet., and PPD 1.0% pet.; 122 patients were also patch tested with DO 3 1.0% pet. Among the 2250 patients patch tested, contact allergy prevalence to TDM 6.6% was 2.4%, to TDM 5.6% 1.8%, and to TDM 7.0% 2.0%. Of the 54 TDM 6.6%-positive patients, 55.6% reacted to PPD; as much as 42.2% of PPD-allergic women and 50% of PPD-allergic men reacted to TDM 6.6%. Of the 17 DO 3-positive patients, 94.1% showed a positive reaction to PPD. Results indicate that DO 3 can probably be omitted from TDM, but patch testing with TDM 6.6%, TDM 7.0%, DO 3 1.0%, and PPD 1.0% simultaneously is needed to finally decide whether it is possible or not.

Sections du résumé

BACKGROUND BACKGROUND
The textile dye mix (TDM) 6.6% pet. contains Disperse Blue (DB) 35, Disperse Yellow 3, Disperse Orange (DO) 1 and 3, Disperse Red 1 and 17, and DB 106 and 124. The most frequent allergen in TDM-positive patients is DO 3. Around 85% of p-phenylenediamine (PPD)-allergic dermatitis patients have shown positive patch test reactions to DO 3. There has been a discussion to exclude DO 3 from TDM 6.6% because of frequent, strong reactions to TDM 6.6% and PPD.
OBJECTIVES OBJECTIVE
To study if DO 3 can be omitted from a TDM.
METHODS METHODS
Patch tests were performed on 2250 dermatitis patients with TDM 6.6%, TDM 5.6% pet., TDM 7.0% pet., and PPD 1.0% pet.; 122 patients were also patch tested with DO 3 1.0% pet.
RESULTS RESULTS
Among the 2250 patients patch tested, contact allergy prevalence to TDM 6.6% was 2.4%, to TDM 5.6% 1.8%, and to TDM 7.0% 2.0%. Of the 54 TDM 6.6%-positive patients, 55.6% reacted to PPD; as much as 42.2% of PPD-allergic women and 50% of PPD-allergic men reacted to TDM 6.6%. Of the 17 DO 3-positive patients, 94.1% showed a positive reaction to PPD.
CONCLUSION CONCLUSIONS
Results indicate that DO 3 can probably be omitted from TDM, but patch testing with TDM 6.6%, TDM 7.0%, DO 3 1.0%, and PPD 1.0% simultaneously is needed to finally decide whether it is possible or not.

Identifiants

pubmed: 32666533
doi: 10.1111/cod.13660
doi:

Substances chimiques

Azo Compounds 0
Coloring Agents 0
Disperse Orange 3 B7J3O076OT

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

387-390

Informations de copyright

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Isaksson M, Ryberg K, Goossens A, Bruze M. Recommendation to include a textile dye mix in the European baseline series. Contact Dermatitis. 2015;73(1):15-20.
Ryberg K, Bråred-Christensson J, Engfeldt M, et al. Patch testing with a textile dye mix in two concentrations - a multicentre study by the Swedish contact dermatitis research group. Acta Derm Venereol. 2015;95(4):427-431.
Ryberg K, Agner T, Andersen KE, et al. Patch testing with a textile dye mix - a multicentre study. Contact Dermatitis. 2014;71(4):215-223.
Seidenari S, Mantovani L, Manzini BM, Pignatti M. Cross-sensitizations between azo dyes and Para-amino compound. A study of 236 azo-dye-sensitive subjects. Contact Dermatitis. 1997;36(2):91-96.
Goon AT, Gilmour NJ, Basketter DA, White IR, Rycroft RJ, McFadden JP. High frequency of simultaneous sensitivity to disperse Orange 3 in patients with positive patch tests to Para-phenylenediamine. Contact Dermatitis. 2003;48(5):248-250.
Winhoven SM, Rutter KJ, Beck MH. Multiple positive allergic reactions from patch testing to p-phenylenediamine and azo dyes. Is this a frequent risk and can it be reduced? Contact Dermatitis. 2008;58(3):182-183.
Bruze M, Isaksson M, Gruvberger B, Frick-Engfeldt M. Recommendation of appropriate amounts of petrolatum preparation to be applied at patch testing. Contact Dermatitis. 2007;56(5):281-285.
Fregert S. Manual of Contact Dermatitis. 2nd ed. Copenhagen; 1981:71-81.
Johansen JD, Aalto-Korte K, Agner T, et al. European Society of Contact Dermatitis guideline for diagnostic patch testing - recommendations on best practice. Contact Dermatitis. 2015;73(4):195-221.

Auteurs

Joanna Stenton (J)

Lund University, Department of Occupational and Environmental Dermatology, Skane University Hospital, Malmö, Sweden.

Jakob Dahlin (J)

Lund University, Department of Occupational and Environmental Dermatology, Skane University Hospital, Malmö, Sweden.

Annarita Antelmi (A)

Lund University, Department of Occupational and Environmental Dermatology, Skane University Hospital, Malmö, Sweden.

Magnus Bruze (M)

Lund University, Department of Occupational and Environmental Dermatology, Skane University Hospital, Malmö, Sweden.

Cecilia Svedman (C)

Lund University, Department of Occupational and Environmental Dermatology, Skane University Hospital, Malmö, Sweden.

Erik Zimerson (E)

Lund University, Department of Occupational and Environmental Dermatology, Skane University Hospital, Malmö, Sweden.

Nils Hamnerius (N)

Lund University, Department of Occupational and Environmental Dermatology, Skane University Hospital, Malmö, Sweden.

Ann Pontén (A)

Lund University, Department of Occupational and Environmental Dermatology, Skane University Hospital, Malmö, Sweden.

Marléne Isaksson (M)

Lund University, Department of Occupational and Environmental Dermatology, Skane University Hospital, Malmö, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH